Jiping Zha
Corporate Officer/Principal bei ADAGENE INC.
Profil
Jiping Zha is currently the Executive Vice President-Clinical Development at Adagene, Inc. Prior to this, he worked as the Executive Director-Translational Sciences at NGM Biopharmaceuticals, Inc. from 2017 to 2021.
He also held positions at Crown Bioscience, Inc. as the Senior Vice President-Drug Discovery Technology, and at The University of Texas Southwestern Medical Center and Harvard Medical School as an Assistant Professor.
Dr. Zha received his doctorate from Zhongshan Hospital Fudan University in 1987 and from The University of Tennessee Health Science Center in 1993.
Aktive Positionen von Jiping Zha
| Unternehmen | Position | Beginn |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01.09.2021 |
Ehemalige bekannte Positionen von Jiping Zha
| Unternehmen | Position | Ende |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Ausbildung von Jiping Zha
| Zhongshan Hospital Fudan University | Doctorate Degree |
| The University of Tennessee Health Science Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADAGENE INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
